ArticleCancer medicine2016

A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients.

Hongnan Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.